Has Mark Owens received payments from drug or device companies?

Yes. Drug and device makers reported $285,671 in general payments to Mark Owens across 355 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Owens did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Owens come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Owens

Psychiatry · Brooklyn, NYNPI 1922218015

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $217,031 of the $285,671 with a category attached, or 76.0%. 10 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 34.1% of the total. Reporting peaked in 2019 at $142,952 and has fallen 97.0% since, to $4,260 in 2024. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$285,671in general payments, 2019–2025

Across 355 payments — averaging $804.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sunovion Pharmaceuticals Inc.$97K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$84K
Ironshore Pharmaceuticals Inc.$49K
Corium, LLC$18K
Supernus Pharmaceuticals, Inc.$12K
Adlon Therapeutics L.p.$10K
plus $16K from 4 others

What the payments were for

Consulting fees$20,3247%
Speaking & faculty fees$217,03176%
Travel & lodging$41,42715%
Food & beverage$6,8522%
Education$170%
Gifts$200%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sunovion Pharmaceuticals Inc.	108	$97,284
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	96	$84,091
Ironshore Pharmaceuticals Inc.	67	$48,914
Corium, LLC	23	$17,528
Supernus Pharmaceuticals, Inc.	19	$12,240
Adlon Therapeutics L.p.	9	$9,542
Takeda Pharmaceuticals U.S.A., Inc.	13	$8,095
Tris Pharma Inc	13	$4,748
Shire North American Group Inc	6	$3,205
Neos Therapeutics, LP	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LATUDA$95,791
CAPLYTA$82,782
Jornay PM 20mg capsules (Bottle of 100)$33,536
Azstarys$16,971
JORNAY PM$14,271
VYVANSE$10,736
ADHANSIA XR$9,455
QELBREE$5,117
Dyanavel XR$4,411
APTIOM$157

How this compares

$285,671 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Other psychiatry in Brooklyn

Nancy Abdel-WahabBrooklyn$253K
Stephan CarlsonBrooklyn$184K
Louis BelzieBrooklyn$161K
Nikhil PalekarBrooklyn$115K
Alexander PinkusovichBrooklyn$95K
Leslie CitromePomona$5.7M
Sanjay GuptaCheektowaga$1.9M
Richard PriceMonsey$1.7M
Adam AshtonAmherst$1.6M
Christoph CorrellGlen Oaks$1.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →